With new cancer detection technology on the horizon, ranging from blood tests to wristbands, understanding overdiagnosis is a huge challenge.
Our new research shows that a one-off PSA test doesn't save lives from prostate cancer.
Inviting men with no symptoms to a one-off PSA test for prostate cancer does not save lives according to results from the largest ever prostate cancer trial.
An experimental hormone therapy delays the spread of prostate cancer that has stopped responding to standard treatment, according to new clinical trial results.
Analysing big data to predict men’s risk of side effects could help personalise radiotherapy treatment for prostate cancer.
Men with unusually low amounts of testosterone in their blood are around 20% less likely to develop prostate cancer.
Availability of robotic prostate cancer surgery could be a bigger draw for patients than quality of hospital
Prostate cancer patients may base choice of hospital for surgery on availability of new technology, rather than hospital quality information, according to study
From this week’s cancer news we look at how HIV research could offer clues about lung cancer and bust headlines about a radiotherapy ‘cure’ for prostate cancer.
A form of radiotherapy targeting the pelvis is safe for men with advanced localised prostate cancer, according to a new study.
Unpublished results from the Cancer Research UK-funded STAMPEDE trial show that two different treatments improve survival in men with advanced prostate cancer.